Sotera Health (SHC) EBITDA (2020 - 2026)

Sotera Health's EBITDA history runs 7 years deep, the most recent figure standing at $78.9 million for Q1 2026.

• In Q1 2026, EBITDA rose 8.96% year-over-year to $78.9 million; the TTM figure through Mar 2026 stood at $399.3 million (up 26.02% YoY), while the FY2025 annual figure was $392.8 million, up 31.97% from the prior year.
• EBITDA for Q1 2026 stood at $78.9 million, down from $108.4 million in the prior quarter.
• The five-year high for EBITDA was $114.3 million in Q3 2025, with the low at $33.4 million in Q1 2023.
• The 5-year median for EBITDA is $76.1 million (2023), against an average of $76.1 million.
• Peak annual rise in EBITDA reached 72.89% in 2023, while the deepest fall reached 37.62% in 2023.
• Sotera Health's EBITDA stood at $60.2 million in 2022, then soared by 72.89% to $104.0 million in 2023, then fell by 16.23% to $87.1 million in 2024, then increased by 24.4% to $108.4 million in 2025, then decreased by 27.26% to $78.9 million in 2026.
• Business Quant data shows SHC's EBITDA at $78.9 million in Q1 2026, $108.4 million in Q4 2025, and $114.3 million in Q3 2025.